Authors
Latest:
Saving the World Through Pharmaceutical InnovationThe COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.
Latest:
Doris Day, MD, Discusses Primary Axillary Hyperhidrosis and Brella SweatControl PatchBrella received FDA clearance last week for improving excessive underarm sweating.
Latest:
Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for ADAlbert Chiou, MD, MBA, discusses early clinical data on soquelitinib for atopic dermatitis, highlighting its targeted ITK inhibition, dose-dependent efficacy, favorable safety profile, and more.
Latest:
Navigating Skin Aging Across Diverse Tones: Tailored Approaches and Cultural AwarenessAn expert in dermatology discusses the intricacies of addressing anti-aging concerns in patients with diverse skin tones, emphasizing the importance of tailoring management to meet their unique needs, understanding the underlying mechanisms of aging, and appreciating the cultural nuances within patient populations.
Latest:
Offering an Insurance Package to Retain and Reward Employees: What Dermatologists Should KnowExplore various elements that can go into a comprehensive insurance benefits package for dermatology practice employees.
Latest:
CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and AgingTake a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
Latest:
Improving Hyperhidrosis Treatment: The Role of IHhSDavid M. Pariser, MD, FACP, FAAD, secretary and a founding board member of the International Hyperhidrosis Society, discussed the latest in hyperhidrosis research and the organization’s commitment to helping clinicians treat the condition.
Latest:
Concluding Remarks: Systemic Treatment Considerations for Atopic Dermatitis in Patients of Childbearing PotentialLooking to the future of atopic dermatitis treatment, Drs Kiracofe and Murase offer concluding remarks on current unmet needs, the benefits of treatment guidelines, and the importance of treating itch in patients who are or may become pregnant.
Latest:
Key Takeaways for Adding Swift Wart Treatment to Your PracticeDustin Portela, DO, discuss how Swift microwave therapy can enhance patient care, generate referrals, and offer a promising revenue stream, while keeping pace with ongoing advancements in the technology.
Latest:
Outlining SCALE 2023 with Brian Biesman, MD, FACSAs co-director, Biesman is looking forward to all attendees being able to find medical and aesthetic sessions relevant to their education.
Latest:
Creating a Telehealth Experience For Postoperative AppointmentsLaura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.
Latest:
Atopic Dermatitis Associated With Higher Dementia RiskThrough a comprehensive review and meta-analysis, researchers identified the correlation between atopic dermatitis and dementia.
Latest:
Jim Lee, MD, PhD, Reflects on New Research at AAD and Advances in Dermatology"It's an exciting time" in dermatology, said Lee, who reflects on late-breaker data and other research presented at the 2024 AAD Annual Meeting.
Latest:
ICYMI: FDA Greenlights Yesintek, Sixth Biosimilar to Stelara, for Psoriasis and Psoriatic ArthritisThe FDA recently approved Yesintek for treating psoriasis, psoriatic arthritis, and IBD, with a 2025 launch expected.
Latest:
My experience with surface radiotherapySuperficial radiation offers a newer, FDA-approved office-based option that is safe. Steven A. Davis, M.D., shares his experience using surface radiotherapy to treat his patients with non-melanoma skin cancer.
Latest:
Combining Surgical Precision With Immunological Innovation in Vitiligo TreatmentMaggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.
Latest:
Advancing Aesthetics: Innovations, Trends, and Patient-Centric Strategies in the Era of Weight Loss MedicationsDiscover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.
Latest:
Looking Ahead to Povorcitininb for HS and the Availability of Generic TofacitinibAt RAD 2025, Matthew Zirwas, MD, outlined 2 upcoming shifts in dermatology: the emergence of povorcitinib for hidradenitis suppurativa and the anticipated generic availability of tofacitinib.
Latest:
Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne VulgarisIn the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.
Latest:
Mastering Dermoscopy and Dysplastic NeviElizabeth Berry, MD, FAAD, reviewed dysplastic nevi as risk markers and highlighted the need for more data on severe cases at AAD 2025.
Latest:
Overview of Prurigo Nodularis for Practicing Dermatology CliniciansIt is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.
Latest:
Neoadjuvant Cemiplimab Induces Promising Pathologic Complete Response in CSCCNeoadjuvant treatment with cemiplimab led to near or complete disappearance of cutaneous squamous cell carcinoma in almost 64% of patients set to undergo surgery.
Latest:
Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician PerspectivesPatient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.
Latest:
Maral Kibarian Skelsey, MD, Shares Insights Into DermTech’s 2-GEP Assay SuccessDermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.
